search
Back to results

Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients (EPOC_2_0)

Primary Purpose

Pulmonary Disease, Chronic Obstructive, Breathing Exercises, Exercise Tolerance

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Exercise training program with and without FB
Sponsored by
University of Cadiz
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pulmonary Disease, Chronic Obstructive focused on measuring Pulmonary rehabilitation, Medical device, FeelBreathe, Exercise intervention, Equipment and Supplies

Eligibility Criteria

35 Years - 65 Years (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • men with diagnosis of COPD according to guidelines criteria
  • with moderate or severe airflow obstruction (GOLD 2 or 3)
  • dyspnea grade 2 or greater by mMRC scale
  • stable clinical condition for at least 2 months.

Exclusion Criteria:

  • poor compliance
  • treatment with oxygen therapy or non-invasive mechanical ventilation
  • CO2 retention
  • medical conditions that can produce or increase dyspnea on exercise in addition to COPD (cardiovascular, metabolic or other respiratory diseases)
  • osteoarticular or neuromuscular diseases that may limit the correct performance of the 6MWT

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Experimental

    No Intervention

    Arm Label

    FB group

    ONB group

    control group (CG)

    Arm Description

    Participants who performed an exercise training program for 8 weeks using a nasal restriction device for inspiratory muscle training, called Feelbreathe®

    Participants who performed an exercise training program for 8 weeks with oronasal breathing without FB

    Participants who received the standard medical recommendations for patients with COPD, but not participated in the exercise intervention program

    Outcomes

    Primary Outcome Measures

    Oxygen uptake during incremental test to exhaustion on treadmill
    mL/min
    Ventilation during incremental test to exhaustion on treadmill
    L/min

    Secondary Outcome Measures

    dyspnea scale
    mMRC (Modified Medical Research Council) Dyspnea Scale. Values from 0 (better) to 4 (worse) about disability attributable to breathlessness
    The COPD Assessment Test (CAT) is a questionnaire for people with Chronic Obstructive Pulmonary Disease (COPD)
    The COPD Assessment Test (CAT) score measures the impact that COPD (Chronic Obstructive Pulmonary Disease) is having on the wellbeing and daily life of the patient. Score from 0 (better) to 40 (worse) about the impact of COPD symptoms on patients' overall health.
    exercise capacity using the distance walked in the six minutes walking test (6MWT)
    distance measured in meters

    Full Information

    First Posted
    April 28, 2019
    Last Updated
    May 29, 2019
    Sponsor
    University of Cadiz
    Collaborators
    Sociedad Española de Neumología y Cirugía Torácica, Hospital Universitario Puerta del Mar, Bahía Sur Andalusian Center for Sports Medicine
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03936348
    Brief Title
    Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients
    Acronym
    EPOC_2_0
    Official Title
    Evaluation of a Respiratory Muscle Training Program Restricting Nasal Breathing With FeelBreathe® Device in COPD Patients
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2019
    Overall Recruitment Status
    Completed
    Study Start Date
    January 15, 2016 (Actual)
    Primary Completion Date
    July 25, 2017 (Actual)
    Study Completion Date
    December 18, 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Cadiz
    Collaborators
    Sociedad Española de Neumología y Cirugía Torácica, Hospital Universitario Puerta del Mar, Bahía Sur Andalusian Center for Sports Medicine

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This study evaluates the effects of a nasal restriction device for inspiratory muscle training (FeelBreathe) after 8 weeks of exercise intervention on exercise capacity, quality of life, dyspnea and inspitarotory muscle strength in patients with stable COPD. Participants were divided in three groups: 1) exercise intervention using the Feelbreathe® device (FB group), 2) exercise intervention with oronasal breathing without FB (ONB group) and 3) no participation in the exercise intervention as control group (CG).
    Detailed Description
    The Feelbreathe® device, tested in the investigator's study can be used in static and dynamic situations and is a nasal ventilatory flow restriction device made by a strip of hypoallergenic material (3M Spain, S.A. Medical Specialties / O.E.M.) that is placed and adhered under the nostrils impairing the free pass of air through the nose by producing resistance to flow. Depend on the size or/and porosity of the device, the inspiratory process is more or less difficult. It can be used while performing dynamic exercise or doing daily living activities. The Feelbreathe® device (FB) has been authorized by the Spanish Agency for Medicines and Health Products for application on COPD patients (Expedient 521/15/EC. AEMPS-Madrid-Spain-Patent Nº: P200902402).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pulmonary Disease, Chronic Obstructive, Breathing Exercises, Exercise Tolerance
    Keywords
    Pulmonary rehabilitation, Medical device, FeelBreathe, Exercise intervention, Equipment and Supplies

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Factorial Assignment
    Model Description
    Patients were randomized to 3 groups. The first one performed a supervised RP using the Feelbreathe® device (FB group), the second group developed the same RP with oronasal breathing without FB (ONB group) and the third was the control group (CG). The RP was conducted during 8 weeks, 3 days per week, and includes a combined training of endurance and strength exercises.
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    16 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    FB group
    Arm Type
    Experimental
    Arm Description
    Participants who performed an exercise training program for 8 weeks using a nasal restriction device for inspiratory muscle training, called Feelbreathe®
    Arm Title
    ONB group
    Arm Type
    Experimental
    Arm Description
    Participants who performed an exercise training program for 8 weeks with oronasal breathing without FB
    Arm Title
    control group (CG)
    Arm Type
    No Intervention
    Arm Description
    Participants who received the standard medical recommendations for patients with COPD, but not participated in the exercise intervention program
    Intervention Type
    Device
    Intervention Name(s)
    Exercise training program with and without FB
    Other Intervention Name(s)
    Pulmonary rehabilitation program
    Intervention Description
    Participants carried out a supervised RP for 8 weeks, 3 days per week. The training sessions lasted 60 minutes and included a warning up phase, the main phase and a recovery phase. After each session, Borg's perceived exertion was measured. The Rehabilitation Program (RP) included aerobic exercise on cycle ergometer and on treadmill (progressing since 10' to 30' and since 40 to 75% of the reserve heart rate (RHR) or 6-7 score based on Borg's perceived exertion), strengthening of lower and upper limb muscles groups, breathing exercises (pursed lip breathing, diaphragmatic and abdominal breathing and diaphragmatic mobility) and finally stretching exercises. In the FB group, for restricted nasal breathing, at the beginning of the training program, the small size device was used (4 mm). The size of the device was progressively increasing according to the patient adaptation to the 5 or 6 mm device, depending on the score on Borg's perceived exertion scale.
    Primary Outcome Measure Information:
    Title
    Oxygen uptake during incremental test to exhaustion on treadmill
    Description
    mL/min
    Time Frame
    8 WEEKS
    Title
    Ventilation during incremental test to exhaustion on treadmill
    Description
    L/min
    Time Frame
    8 WEEKS
    Secondary Outcome Measure Information:
    Title
    dyspnea scale
    Description
    mMRC (Modified Medical Research Council) Dyspnea Scale. Values from 0 (better) to 4 (worse) about disability attributable to breathlessness
    Time Frame
    8 WEEKS
    Title
    The COPD Assessment Test (CAT) is a questionnaire for people with Chronic Obstructive Pulmonary Disease (COPD)
    Description
    The COPD Assessment Test (CAT) score measures the impact that COPD (Chronic Obstructive Pulmonary Disease) is having on the wellbeing and daily life of the patient. Score from 0 (better) to 40 (worse) about the impact of COPD symptoms on patients' overall health.
    Time Frame
    8 WEEKS
    Title
    exercise capacity using the distance walked in the six minutes walking test (6MWT)
    Description
    distance measured in meters
    Time Frame
    8 WEEKS

    10. Eligibility

    Sex
    Male
    Minimum Age & Unit of Time
    35 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: men with diagnosis of COPD according to guidelines criteria with moderate or severe airflow obstruction (GOLD 2 or 3) dyspnea grade 2 or greater by mMRC scale stable clinical condition for at least 2 months. Exclusion Criteria: poor compliance treatment with oxygen therapy or non-invasive mechanical ventilation CO2 retention medical conditions that can produce or increase dyspnea on exercise in addition to COPD (cardiovascular, metabolic or other respiratory diseases) osteoarticular or neuromuscular diseases that may limit the correct performance of the 6MWT
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jose L González Montesinos, PhD
    Organizational Affiliation
    University of Cádiz
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    Since there is personal and not transferable data
    Citations:
    Citation
    González-Montesinos JL, Vaz Pardal C, Fernández Santos JR, Arnedillo Muñoz A CSJ y GE de los MR. Efectos del entrenamiento de la musculatura respiratoria sobre el rendimiento. Revisión bibliográfica. Rev Andal Med Deport. 2012;5(4):163-70.
    Results Reference
    background
    Citation
    González Montesinos JL, Costa Sepúlveda JL, Fernández Santos J, Gómez Espinosa de los Monteros R, Mora Vicente J, Castro Piñero J y, et al. Dispositivo de Restricción y Filtrado del Flujo Ventilatorio Nasal. P200902402, 2011. p. 1-4.
    Results Reference
    result
    PubMed Identifier
    27238811
    Citation
    Gonzalez-Montesinos JL, Ponce-Gonzalez JG, Vicente-Campos D, Lopez-Chicharro J, Fernandez-Santos Jdel R, Vaz-Pardal C, Costa-Sepulveda JL, Conde-Caveda J, Castro-Pinero J. Efectos de un dispositivo de restriccion ventilatoria nasal sobre la ventilacion pulmonar e intercambio gaseoso durante el ejercicio en personas sanas. Nutr Hosp. 2016 Mar 25;33(2):130. doi: 10.20960/nh.130.
    Results Reference
    result
    PubMed Identifier
    11069801
    Citation
    Scherer TA, Spengler CM, Owassapian D, Imhof E, Boutellier U. Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life. Am J Respir Crit Care Med. 2000 Nov;162(5):1709-14. doi: 10.1164/ajrccm.162.5.9912026.
    Results Reference
    result
    PubMed Identifier
    27822031
    Citation
    Wada JT, Borges-Santos E, Porras DC, Paisani DM, Cukier A, Lunardi AC, Carvalho CR. Effects of aerobic training combined with respiratory muscle stretching on the functional exercise capacity and thoracoabdominal kinematics in patients with COPD: a randomized and controlled trial. Int J Chron Obstruct Pulmon Dis. 2016 Oct 28;11:2691-2700. doi: 10.2147/COPD.S114548. eCollection 2016.
    Results Reference
    result
    PubMed Identifier
    27730178
    Citation
    Camillo CA, Osadnik CR, van Remoortel H, Burtin C, Janssens W, Troosters T. Effect of "add-on" interventions on exercise training in individuals with COPD: a systematic review. ERJ Open Res. 2016 Mar 29;2(1):00078-2015. doi: 10.1183/23120541.00078-2015. eCollection 2016 Jan.
    Results Reference
    result

    Learn more about this trial

    Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients

    We'll reach out to this number within 24 hrs